Lower vs higher oxygenation target and days alive without life support in COVID-19: The HOT-COVID randomized clinical trial
…, BA Brand, N Haase, SA Iversen, KV Marcussen… - JAMA, 2024 - jamanetwork.com
Importance Supplemental oxygen is ubiquitously used in patients with COVID-19 and severe
hypoxemia, but a lower dose may be beneficial. Objective To assess the effects of targeting …
hypoxemia, but a lower dose may be beneficial. Objective To assess the effects of targeting …
Low vs high hemoglobin trigger for transfusion in vascular surgery: a randomized clinical feasibility trial
…, D Hellemann, P Winkel, KV Marcussen… - Blood, The Journal …, 2019 - ashpublications.org
Current guidelines advocate to limit red blood cell (RBC) transfusion during surgery, but the
feasibility and safety of such a strategy remain unclear, as the majority of evidence is based …
feasibility and safety of such a strategy remain unclear, as the majority of evidence is based …
Oxygenation targets in ICU patients with COVID‐19: A post hoc subgroup analysis of the HOT‐ICU trial
…, SR Aagaard, MH Bestle, KV Marcussen… - Acta …, 2022 - Wiley Online Library
Background Supplemental oxygen is the key intervention for severe and critical COVID‐19
patients. With the unstable supplies of oxygen in many countries, it is important to define the …
patients. With the unstable supplies of oxygen in many countries, it is important to define the …
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial
IMPORTANCE Dexamethasone 6 mg daily is recommended for up to 10 days in patients
with severe and critical COVID-19, but a higher dose may benefit those with more severe …
with severe and critical COVID-19, but a higher dose may benefit those with more severe …
[HTML][HTML] Comparing the effects of continuous positive airway pressure via mask or helmet interface on oxygenation and pulmonary complications after major …
…, RB Strandby, L Henningsen, KV Marcussen… - Journal of Clinical …, 2023 - Springer
The risk of pulmonary complications is high after major abdominal surgery but may be reduced
by prophylactic postoperative noninvasive ventilation using continuous positive airway …
by prophylactic postoperative noninvasive ventilation using continuous positive airway …
[HTML][HTML] Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia–a …
…, C Gluud, V Kadam, KV Marcussen… - The Lancet Regional …, 2024 - thelancet.com
Background In the COVID-STEROID 2 trial there was suggestion of heterogeneity of treatment
effects (HTE) between patients enrolled from Europe vs. India on the primary outcome. …
effects (HTE) between patients enrolled from Europe vs. India on the primary outcome. …
Effect of low vs high haemoglobin transfusion trigger on cardiac output in patients undergoing elective vascular surgery: Post‐hoc analysis of a randomized trial
…, OB Pedersen, KV Marcussen… - Acta …, 2021 - Wiley Online Library
Background During vascular surgery, restricted red‐cell transfusion reduces frontal lobe
oxygen (ScO 2 ) saturation as determined by near‐infrared spectroscopy. We evaluated …
oxygen (ScO 2 ) saturation as determined by near‐infrared spectroscopy. We evaluated …
Septic shock in intensive care
A Perner, S Carlsen, K Marcussen, N Wesche… - Ugeskrift for …, 2010 - europepmc.org
Results A total of 132 patients with a median age of 64 years (range 15-92 years) were
included. Patients were primarily admitted from general wards (n= 56), operation-(31) and …
included. Patients were primarily admitted from general wards (n= 56), operation-(31) and …
Gene expression signatures predict outcome in non–muscle-invasive bladder carcinoma: a multicenter validation study
…, AMK Hein, JL Jensen, KME Jensen, N Marcussen… - Clinical Cancer …, 2007 - AACR
Purpose: Clinically useful molecular markers predicting the clinical course of patients diagnosed
with non–muscle-invasive bladder cancer are needed to improve treatment outcome. …
with non–muscle-invasive bladder cancer are needed to improve treatment outcome. …
Gene Expression in the Urinary Bladder: A Common Carcinoma in Situ Gene Expression Signature Exists Disregarding Histopathological Classification
L Dyrskjøt, M Kruhøffer, T Thykjaer, N Marcussen… - Cancer research, 2004 - AACR
The presence of carcinoma in situ (CIS) lesions in the urinary bladder is associated with a
high risk of disease progression to a muscle invasive stage. In this study, we used microarray …
high risk of disease progression to a muscle invasive stage. In this study, we used microarray …